Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 100 M82 M83 M77 M81 M110 M 351 M Research & development —————— — Operating income 533 M239 M484 M355 M405 M398 M 1.64 B Non-Operating Income, Total 26 M31 M-1 M43 M8 M42 M 92 M Interest expense, net of interest capitalized 127 M133 M135 M159 M167 M153 M 614 M Non-Operating Income, excl. Interest Expenses -127 M-133 M-150 M-153 M-167 M-153 M -623 M Unusual income/expense 26 M31 M14 M37 M8 M42 M 101 M Pretax income 566 M231 M459 M322 M335 M376 M 1.49 B Equity in earnings 103 M94 M96 M89 M89 M89 M 363 M Taxes 50 M4 M6 M-4 M1 M100 M 103 M Non-controlling/minority interest 73 M87 M88 M86 M79 M95 M 348 M After tax other income/expense -18 M-13 M-15 M32 M-29 M2 M -10 M Net income before discontinued operations 307 M140 M365 M240 M255 M181 M 1.04 B Discontinued operations 136 M70 M76 M102 M-103 M1.65 B 1.72 B Net income 443 M210 M441 M342 M152 M1.83 B 2.77 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 443 M210 M441 M342 M152 M1.83 B 2.77 B Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) —————— — Average basic shares outstanding —————— — Diluted shares outstanding —————— — EBITDA 795 M474 M714 M611 M648 M640 M 2.61 B EBIT 533 M239 M484 M355 M405 M398 M 1.64 B Cost of revenue 10.76 B9.76 B10.59 B9.33 B11.49 B16.56 B 47.96 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 262 M235 M230 M256 M243 M242 M 971 M